Anti-TRIL antibodies are used in the immunodetection of the protein TLR4 interactor with leucine rich repeats. In humans, the canonical protein has a reported length of 811 amino acid residues and a mass of 88.7 kDa. Its subcellular localization is in the membrane. It is reported to be highly expressed in the brain, ovary, small intestine and spleen. TRIL is a known component of the TLR4 signaling complex. Post-translational modifications have been described, including glycosylation. TRIL gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. These TRIL antibodies are widely used in Western Blot experiments, among other applications.